MED10

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MED10 mutation is significantly associated with the immune_cell of many other genes, with 1 significant associations in total. BRCA shows the largest number of these associations.

The most reproducible MED10-associated genes across cancer lineages are CD4+ Tem. Each is linked with MED10 in more than 1 cancer types. Because this analysis shows association rather than direction, both MED10-to-partner and partner-to-MED10 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD4+ Tem grouped by MED10-low versus MED10-high in BRCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MED10→partner) and Y-score (partner→MED10) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACD4+ Tem →+0.021+6.234<.001.02631
Each partner links to its Q-omics profile. Showing the 1 strongest of 1 associations by consensus.

CD4+ Tem by MED10 expression — BRCA

Box plot of CD4+ Tem in MED10-low vs MED10-high samples in BRCA.

Explore this box plot interactively →

Exploration